Pyrazole P38 map kinase inhibitors
US10000471B2 · kind B2 · utility
0Cited by
1References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2017 |
| Grant date | Jun 19, 2018 |
| Priority date | — |
| Expiry date | Aug 29, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided inter alia compounds of formula (I) wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.